The global CRISPR-based gene editing market size is projected to grow from USD 4.46 billion in 2025 to over USD 13.39 billion by 2034, expanding at a CAGR of 13%. Growth is fueled by advancements in ...

CRISPR is giving us a rare opportunity, then, to escape GMO definitions stuck in the 1980s and begin treating agriculture and food as the complex systems they are. It invites us to update biotech ...

The market for CRISPR is primarily driven by the rising need for targeted medical treatments, the growth of biotechnology and agricultural applications, and improvements in delivery methods.

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.

Applications of the CRIPSR/Cas9 system to plants was of great interest at the Plant and Animal Genomics Conference held in San Diego this past January.

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

Shares of CRISPR Therapeutics CRSP have rallied 41.4% in the past three months, driven by encouraging data from a study of ...